Clindamycin Injection ADD-Vantage Vials by Alvogen: Recall - Lack of Sterility Assurance

[Posted 06/16/2017]

AUDIENCE: Pharmacy, Health Professional, Infectious Disease

ISSUE: Alvogen is voluntarily recalling seven lots of Clindamycin Injection USP ADD-Vantage Vials to the hospital/retail level due to microbial growth detected during a routine simulation of the manufacturing process, which represents the potential introduction of microorganisms into the product. Clindamycin Injection is manufactured for Alvogen by Hospira Inc., a Pfizer Company.

Learn more.